invivodata’s DiaryPRO Collects Primary Endpoint Data for Phase II Clinical Study

invivodata’s DiaryPRO solution used by patients to report daily pain frequency and severity.

This article is located at another site and will open a new window or tab in your browser. Some links may require Adobe Acrobat Reader. To continue reading, please click here:

http://www.invivodata.com/corp/invivodata_Depomed.htm?print=1